Dermata Stock Financials

DRMA -  USA Stock  

USD 2.45  0.27  9.93%

Understanding current and past Dermata Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Dermata Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Dermata Therapeutics' assets may result in an increase in income on the income statement. Because of this, it is necessary to analyze all of Dermata Therapeutics' financials over time to get the whole picture.
.
We urge to utilize analysis of Dermata Therapeutics fundamentals to see if markets are presently mispricing the company. We have collected data for one available fundamental indicators for Dermata Therapeutics, which can be compared to its rivals. Use Dermata Therapeutics to protect your portfolios against small market fluctuations. The stock experiences a very speculative upward sentiment. Check odds of Dermata Therapeutics to be traded at $2.33 in 90 days.

Dermata Fundamentals 

 
Refresh
With this module, you can analyze Dermata financials for your investing period. You should be able to track the changes in Dermata Therapeutics individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Chance Of Financial Distress
Over 62
Dermata Therapeutics has more than 62 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Dermata Therapeutics stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Dermata Therapeutics' official financial statements usually reflect Dermata Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Dermata Therapeutics. For example, before you start analyzing numbers published by Dermata accountants, it's critical to develop an understanding of what Dermata Therapeutics' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Dermata Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Dermata Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Dermata Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Dermata Therapeutics. Please utilize our Beneish M Score to check the likelihood of Dermata Therapeutics' management to manipulate its earnings.
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CUSIP249845108
Older SymbolDRMAW
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
CurrencyUSD - US Dollar

Dermata Therapeutics Systematic Risk

Dermata Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Dermata Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Dermata Therapeutics correlated with the market. If Beta is less than 0 Dermata Therapeutics generally moves in the opposite direction as compared to the market. If Dermata Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Dermata Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Dermata Therapeutics is generally in the same direction as the market. If Beta > 1 Dermata Therapeutics moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

About Dermata Therapeutics Financials

What exactly are Dermata Therapeutics Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Dermata Therapeutics' income statement, its balance sheet, and the statement of cash flows. Potential Dermata Therapeutics investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Dermata Therapeutics investors may use each financial statement separately, they are all related. The changes in Dermata Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dermata Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
 2010 2020 2021 (projected)
Current Assets2.07 M605.45 K880.96 K
Total Assets2.07 M605.45 K881.03 K
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines that you should keep in mind when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase year after year due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt to equity ratio because this number will tell you how much risk it has. If a company such as Dermata Therapeutics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to try and figure out if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that net revenue of Dermata grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only grown by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Dermata Therapeutics December 1, 2021 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Dermata Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Dermata Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Dermata Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Dermata Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Dermata Therapeutics's daily price indicators and compare them against related drivers.
Information Ratio(0.08)
Maximum Drawdown46.96
Value At Risk(13.10)
Potential Upside13.86
Continue to Investing Opportunities. Note that the Dermata Therapeutics information on this page should be used as a complementary analysis to other Dermata Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Dermata Stock analysis

When running Dermata Therapeutics price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Is Dermata Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermata Therapeutics. If investors know Dermata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dermata Therapeutics is measured differently than its book value, which is the value of Dermata that is recorded on the company's balance sheet. Investors also form their own opinion of Dermata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dermata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermata Therapeutics' market value can be influenced by many factors that don't directly affect Dermata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Dermata Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.